Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bastien Gerby

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Anticancer Research|August 5, 2010
Iodination increases the activity of verapamil derivatives in reversing PGP multidrug resistanceRegis Barattin, Bastien Gerby, Kevin Bourges, et al.
Plos Genetics|December 19, 2014
SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cellsBastien Gerby, Cedric S Tremblay, Mathieu Tremblay, et al.
The Journal of Experimental Medicine|September 22, 2010
NKX3.1 is a direct TAL1 target gene that mediates proliferation of TAL1-expressing human T cell acute lymphoblastic leukemiaSophie Kusy, Bastien Gerby, Nicolas Goardon, et al.
Ejhaem|March 9, 2026
Selumetinib as an Effective Therapy of Histiocytic Sarcoma Evolving From a B-Cell Acute Lymphoblastic LeukaemiaLaetitia Largeaud, Charlotte Syrykh, Julie Vial, et al.
Frontiers in Immunology|April 11, 2022
Monoallelic <i>Heb/Tcf12</i> Deletion Reduces the Requirement for NOTCH1 Hyperactivation in T-Cell Acute Lymphoblastic LeukemiaDiogo F T Veiga, Mathieu Tremblay, Bastien Gerby, et al.
Oncotarget|September 15, 2018
Charlotte Cresson, Sophie Péron, Laura Jamrog, et al.
Blood Cancer Journal|January 30, 2025
GATA2 mutated allele specific expression is associated with a hyporesponsive state of HSC in GATA2 deficiency syndromeLaetitia Largeaud, Vincent Fregona, Laura A Jamrog, et al.
Blood|November 6, 2008
NOTCH is a key regulator of human T-cell acute leukemia initiating cell activityFlorence Armstrong, Philippe Brunet de la Grange, Bastien Gerby, et al.
Cancer Research|May 12, 2025
Modeling the PAX5P80R Mutation Reveals HIF2α Activation as a Common Feature and Therapeutic Target in B-Cell Acute Lymphoblastic LeukemiaManon Bayet, Vincent Fregona, Mathieu Bouttier, et al.
Oncogene|May 23, 2026
Signals from the bone marrow B cell niches shape pre-leukemic fate in a murine model of B cell acute lymphoblastic leukemiaMarjorie C Delahaye, Simon Léonard, Jeoffrey Pelletier, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Anticancer Research|August 5, 2010
Iodination increases the activity of verapamil derivatives in reversing PGP multidrug resistanceRegis Barattin, Bastien Gerby, Kevin Bourges, et al.
Plos Genetics|December 19, 2014
SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cellsBastien Gerby, Cedric S Tremblay, Mathieu Tremblay, et al.
The Journal of Experimental Medicine|September 22, 2010
NKX3.1 is a direct TAL1 target gene that mediates proliferation of TAL1-expressing human T cell acute lymphoblastic leukemiaSophie Kusy, Bastien Gerby, Nicolas Goardon, et al.
Ejhaem|March 9, 2026
Selumetinib as an Effective Therapy of Histiocytic Sarcoma Evolving From a B-Cell Acute Lymphoblastic LeukaemiaLaetitia Largeaud, Charlotte Syrykh, Julie Vial, et al.
Frontiers in Immunology|April 11, 2022
Monoallelic <i>Heb/Tcf12</i> Deletion Reduces the Requirement for NOTCH1 Hyperactivation in T-Cell Acute Lymphoblastic LeukemiaDiogo F T Veiga, Mathieu Tremblay, Bastien Gerby, et al.
Oncotarget|September 15, 2018
Charlotte Cresson, Sophie Péron, Laura Jamrog, et al.
Blood Cancer Journal|January 30, 2025
GATA2 mutated allele specific expression is associated with a hyporesponsive state of HSC in GATA2 deficiency syndromeLaetitia Largeaud, Vincent Fregona, Laura A Jamrog, et al.
Blood|November 6, 2008
NOTCH is a key regulator of human T-cell acute leukemia initiating cell activityFlorence Armstrong, Philippe Brunet de la Grange, Bastien Gerby, et al.
Cancer Research|May 12, 2025
Modeling the PAX5P80R Mutation Reveals HIF2α Activation as a Common Feature and Therapeutic Target in B-Cell Acute Lymphoblastic LeukemiaManon Bayet, Vincent Fregona, Mathieu Bouttier, et al.
Oncogene|May 23, 2026
Signals from the bone marrow B cell niches shape pre-leukemic fate in a murine model of B cell acute lymphoblastic leukemiaMarjorie C Delahaye, Simon Léonard, Jeoffrey Pelletier, et al.
Pageof 3